Belantamab mafodotin
Generic name: belantamab mafodotin [ bel-AN-ta-mab-MA-foe-DOE-tin ]
Brand name: Blenrep
Dosage form: intravenous powder for injection (blmf 100 mg)
Drug class:Miscellaneous antineoplastics
What is belantamab mafodotin?
Belantamab mafodotin is used to treat multiple myeloma in adults. belantamab mafodotin is given after at least 4 other treatments did not work or have stopped working.
Belantamab mafodotin was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, some people responded to this medicine, but further studies are needed.
Belantamab mafodotin is available only under a special program. You must be registered in the program and understand the risks and benefits of this medicine.
Belantamab mafodotin may also be used for purposes not listed in this medication guide.
Warnings
An eye doctor will need to examine your eyes before each dose of this medicine. Belantamab mafodotin can cause eye problems that may lead to blurred vision, an ulcer on the surface of your eye, or vision loss.
Before taking this medicine
Tell your doctor if you have ever had:
problems with your eyes;
vision problems; or
bleeding problems.
You may need to have a negative pregnancy test before starting this treatment.
Belantamab mafodotin can harm an unborn baby if the mother or the father is using belantamab mafodotin.
If you are a woman, do not use belantamab mafodotin if you are pregnant. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 4 months after your last dose.
If you are a man, use effective birth control if your sex partner is able to get pregnant. Keep using birth control for at least 6 months after your last dose.
Tell your doctor right away if a pregnancy occurs while either the mother or the father is using belantamab mafodotin.
This medicine may affect fertility (ability to have children) in both men and women. However, it is important to use birth control to prevent pregnancy because belantamab mafodotin can harm an unborn baby.
Do not breastfeed while using this medicine, and for at least 3 months after your last dose.
How is belantamab mafodotin given?
Belantamab mafodotin is given as an infusion into a vein, usually every 3 weeks. A healthcare provider will give you this injection.
This medicine must be given slowly, and the infusion can take at least 30 minutes to complete.
An eye doctor will need to examine your eyes before each dose of this medicine. Belantamab mafodotin may cause changes to the surface of your eyes, which can lead to vision changes. More seriou...
